ROCKET PHARMACEUTICALS, INC. (RCKT) › Operating IncomeROCKET PHARMACEUTICALS, INC. (RCKT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$7.70M2015: -$20.40M2016: -$7.57M2017: -$19.77M2018: -$71.16M2019: -$76.15M2020: -$134.30M2021: -$167.25M2022: -$224.34M2023: -$259.66M2024: -$273.20M2025: -$231.75M-$231.75M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$231.75M+15.2%2024-$273.20M-5.2%2023-$259.66M-15.7%2022-$224.34M-34.1%2021-$167.25M-24.5%2020-$134.30M-76.4%2019-$76.15M-7.0%2018-$71.16M-259.9%2017-$19.77M-161.1%2016-$7.57M+62.9%2015-$20.40M-164.7%2014-$7.70M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share